As ORMDL3 is a major regulator of SPT, the rate limiting enzyme that catalyzes all sphingolipid biosynthesis, we posit that increased ORMDL3 expression and dysregulation of sphingolipid levels likely exacerbates asthma through effects in multiple cell types, including T cells. This evidence concerns the gene ORMDL3 and asthma.